Thu, January 12, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Christopher Parkinson Maintained (ALB) at Hold with Decreased Target to $300 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Hamza Fodderwala Downgraded (TENB) to Hold and Decreased Target to $44 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Scott Deuschle Maintained (TDG) at Buy with Increased Target to $735 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Shagun Singh Maintained (TFX) at Buy and Held Target at $290 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Benjamin Nolan Maintained (UNP) at Hold with Decreased Target to $212 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Kyle Voigt Maintained (TW) at Hold with Increased Target to $82 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Gautam Sawant Maintained (TW) at Buy with Increased Target to $80 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Sam Margolin Upgraded (TTE) to Buy and Held Target at $72 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Andrew Uerkwitz Downgraded (U) to Sell and Held Target at $19 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Susan Maklari Maintained (TPX) at Strong Buy with Increased Target to $42 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
James Molloy Reiterated (TNXP) at Strong Buy on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Chris Bottiglieri Upgraded (TSCO) to Buy on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Christopher Parkinson Maintained (CE) at Hold with Decreased Target to $107 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Christopher Parkinson Maintained (CCK) at Strong .. with Increased Target to $100 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Brendan Lynch Downgraded (CCI) to Hold and Decreased Target to $152 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Benjamin Budish Maintained (BX) at Hold with Increased Target to $86 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Eric Stine Maintained (BWEN) at Strong Buy with Increased Target to $9 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Matt VanVliet Initiated (BRZE) at Strong Buy and Held Target at $34 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Tyler Radke Downgraded (SMWB) to Hold on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Anthony Crowdell Maintained (SO) at Hold with Decreased Target to $72 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Chris Robertson Maintained (STNG) at Hold with Increased Target to $55 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Ebrahim Poonawala Initiated (STT) at Hold and Held Target at $86 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Andrew Uerkwitz Downgraded (SPOT) to Hold and Decreased Target to $95 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Christopher Parkinson Maintained (AXTA) at Strong .. y with Increased Target to $30 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Aleksey Yefremov Maintained (AXTA) at Buy with Increased Target to $30 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Susan Maklari Maintained (AZEK) at Strong Buy with Increased Target to $27 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Scott Deuschle Upgraded (BA) to Hold and Held Target at $200 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Christopher Parkinson Maintained (BALL) at Hold with Increased Target to $53 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Chris Bottiglieri Downgraded (BBY) to Hold on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Alex Yao Upgraded (BEKE) to Buy and Increased Target to $23 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Brendan Nosal Downgraded (BFC) to Hold and Decreased Target to $95 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Ken Wong Maintained (VEEV) at Buy with Decreased Target to $225 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Matthew Niknam Upgraded (AMT) to Strong Buy and Increased Target to $254 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Tyler Radke Downgraded (AMPL) to Hold and Decreased Target to $13 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Taylor McGinnis Downgraded (AMPL) to Hold and Decreased Target to $14 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Mark Shmulik Maintained (AMZN) at Buy and Held Target at $125 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Lloyd Walmsley Maintained (AMZN) at Strong Buy and Held Target at $125 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Christopher Parkinson Maintained (APD) at Strong .. with Increased Target to $330 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Peter Clark Downgraded (APD) to Hold and Held Target at $340 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Susan Maklari Maintained (AOS) at Strong Sell with Increased Target to $55 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Aleksey Yefremov Maintained (WLK) at Sell with Increased Target to $95 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Brad Erickson Upgraded (WIX) to Buy and Increased Target to $100 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
David Wright Upgraded (VOD) to Strong Buy on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Christopher Allen Downgraded (VIRT) to Hold and Decreased Target to $23 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Brandon Vazquez Upgraded (XRAY) to Hold on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Abbie Zvejnieks Maintained (CAL) at Hold with Decreased Target to $26 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Kyle Voigt Maintained (CBOE) at Hold with Increased Target to $140 on, Jan 12th, 2023
[ Thu, Jan 12th 2023 ]: WOPRAI
Christopher Parkinson Maintained (ASH) at Strong .. with Increased Target to $141 on, Jan 12th, 2023

Brandon Vazquez Upgraded (XRAY) to Hold on, Jan 12th, 2023

Brandon Vazquez of William Blair, Upgraded "DENTSPLY SIRONA Inc." (XRAY) to Hold on, Jan 12th, 2023.

Brandon has made no other calls on XRAY in the last 4 months.



There are 2 other peers that have a rating on XRAY. Out of the 2 peers that are also analyzing XRAY, 1 agrees with Brandon's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Nathan Rich of "Goldman Sachs" Maintained at Hold with Decreased Target to $34 on, Wednesday, November 16th, 2022


This is the rating of the analyst that currently disagrees with Brandon

  • Erin Wright of "Morgan Stanley" Maintained at Buy with Decreased Target to $39 on, Tuesday, November 15th, 2022